Long-Term Follow-up of 100 High-Risk Renal Transplant Recipients Converted From Calcineurin Inhibitors to Sirolimus: A Single Center Experience

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1666-1670

  Halim, M A ^a   Al Otaibi, T ^a   Johny, K V ^a   Hamid, M H ^a   Tawab, K A ^a   Balaha, M A ^a   Abraham, M ^a   Said, T ^a   Nair, M P ^a   Al Waheeb, S ^a   Al Muzairai, I ^a   Nampoory, M R N ^a  

^a IBN SINA HOSPITAL   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; COTRIMOXAZOLE; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; ADULT; ARTICLE; BODY MASS; BONE MARROW SUPPRESSION; CHEST INFECTION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG INDICATION; DRUG INDUCED HEADACHE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EDEMA; FEMALE; FOLLOW UP; GASTROINTESTINAL INFECTION; GASTROINTESTINAL SYMPTOM; GRAFT INFECTION; GRAFT SURVIVAL; HEMOLYTIC UREMIC SYNDROME; HERPES ZOSTER; HIGH RISK PATIENT; HLA MATCHING; HUMAN; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL PNEUMONIA; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; NUTRITIONAL STATUS; OBESITY; ORGAN DONOR; OUTCOME ASSESSMENT; PERICARDITIS; PRIORITY JOURNAL; PROTEINURIA; RECIPIENT; SEPTICEMIA; SKIN INFECTION; SURVIVAL RATE; TREATMENT RESPONSE; TUBERCULOUS PERITONITIS; UPPER RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION; VIRUS INFECTION; WOUND DEHISCENCE; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

ADULT; AZATHIOPRINE; CALCINEURIN; CREATININE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTRACRANIAL HYPERTENSION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; SIROLIMUS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 67249140650     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.100     Document Type: Article

References (18)

1. Cecka J.M. The UNOS Scientific Renal Transplant Registry. In: Cecka J.M., and Terasaki P.I. (Eds). Clinical Transplants 2001 (2002), UCLA Immunogenetics Center, Los Angeles, Calif 1
2. Larson T.S., Dean P.G., Stegall M.D., et al. Complete avoidence of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus. Am J Transplant 6 (2006) 514
3. Sennesael J.J., Bosmans J.L., Bogers J.P., et al. Conversion from cyclosporine to sirolimus in stable renal transplant recipients. Transplantation 80 (2005) 1578
4. Oberbauer R., Segoloni G., Campistol J.M., et al. Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation. Transpl Int 18 (2005) 22
5. Renders L., Steinbach R., Valerius T., et al. Low-dose sirolimus in combination with mycophenolate mofetil improved kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs. Kidney Blood Press Res 27 (2004) 181
6. Hamdy A.F., El-Agroudy A.E., Bakr M.A., et al. Comparison of sirolimus with low-dose tacrolimus versus sirolimus-based calcineurin inhibitor-free regimen in live donor renal transplantation. Am J Transplant 5 (2005) 2531
7. Bumbea V., Kamar N., Ribes D., et al. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Nephrol Dial Transplant 20 (2005) 2517
8. Augustine J.J., Bodziak K.A., and Hricik D.E. Use of sirolimus in solid organ transplantation. Drugs 67 (2007) 369
9. Lieberthal W., Fuhro R., Andry C., et al. Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance. Transplantation 82 (2006) 17
10. Podder H., Podbielski J., Hussein I., et al. Sirolimus improves the two-year outcome of renal allografts in African-American patients. Transpl Int 14 (2001) 135
11. Hricik D.E., Anton H.A., Knauss T.C., et al. Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. Transplantation 74 (2002) 189
12. Cattaneo D., Merlini S., Zenoni S., et al. Influence of co-medication with sirolimus or cyclosporine on mycophenolic acid pharmacokinetics in kidney transplantation. Am J Transplant 5 (2005) 2937
13. Meng-Kun T., Chih-Yuan L., and Rey-Heng H. Conversion to combined therapy with sirolimus and mycophenolate mofetil improved renal function in stable renal transplant recipients. J Formos Med Assoc 106 (2007) 372
14. Hasse J.M. Nutrition assessment and support of organ transplant recipients. J Parenter Enteral Nutr 25 (2001) 120
15. Tritt L. Nutritional assessment and support of kidney transplant recipients. J Infus Nurs 27 (2004) 45
16. Meier-Kriesche H.U., Arndorfer J.A., and Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 73 (2002) 70
17. Siddiqi N., McBride M.A., and Hariharan S. Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis. Kidney Int 65 (2004) 1906
18. Gaber A.O., Kahan B.D., Van Buren C., et al. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial. Transplantation 86 (2008) 1187